Found 91 matching trials
A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer PHASE1 This is an open-label, parallel designed study to assess the pharmacokineti...
Show More Location
Sir Run Run Shaw Hospital
Learn More & Join Trial
Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors PHASE2 This study is a single-arm, multi-center, prospective clinical study aimed ...
Show More Location
The Second Affiliated Hospital of Soochow University
Learn More & Join Trial
Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer N/A Study BT-CL-PGG-CRC0821 is a Phase 2, open-label, multicenter, efficacy and...
Show More Location
University of Minnesota
Learn More & Join Trial
A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC PHASE1 Colorectal cancer (CRC) is one of the most common human malignant tumors. T...
Show More Location
Shanghai East Hospital Phase 1 Clinical Trial Center
Learn More & Join Trial
A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer PHASE1 This is a phase 1/2, multi-center study with an open-label, dose escalation...
Show More Location
California Cancer Associates for Research and Excellence
Learn More & Join Trial
Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid) PHASE1 The MIRROR study is a prospective, single center phase I feasibility and do...
Show More Learn More & Join Trial
Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck PHASE2 This study targets an adult population of patients with recurrent or metast...
Show More Location
Centre hospitalier Régional de Metz-Thionville
Learn More & Join Trial
FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II) PHASE2 This is a prospective, multicenter, randomized controlled, phase II study. ...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation PHASE2 Study Design: a Phase II, single-arm, multicenter, prospective, interventio...
Show More Location
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University,
Learn More & Join Trial
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. PHASE2 Phase II clinical study of irinotecan liposome (II)-based combination regim...
Show More Location
Chinese PLA General Hospital, Beijing,
Learn More & Join Trial